Charlottesville, VA — December 5, 2005 — Diffusion Pharmaceuticals LLC, a drug discovery and development company pioneering a revolutionary mechanism of action to treat life-threatening diseases, today announced that it has completed a $1.35 million private equity round. Proceeds will be used to transition trans sodium crocetinate (TSC), the company’s lead compound, to the clinical [...]

Diffusion Pharmaceuticals LLC selected to present at 2005 Mid-Atlantic Bio, the region’s premier biotechnology forum, October 26-27 at the Ronald Reagan Building and International Trade Center in Washington, DC. Only two of the 15 presenting companies are Virginia-based. Article on PRNewswire

Charlottesville, VA — July 1, 2005 — Diffusion Pharmaceuticals LLC, a drug discovery and development company pioneering a revolutionary mechanism of action to treat life-threatening diseases, today announced the completion of its laboratory and research capabilities expansion. Since June, the company has added three people to oversee activities in its laboratories: Dr. John Gainer, company [...]

Charlottesville, VA, June 15, 2005—The Virginia Piedmont Technology Council (VPTC), the most vibrant tech-focused business alliance in Central Virginia, elected its officers and board of directors for 2005-2006 at the Council’s annual membership lunch held on Wednesday, June 15. Outgoing Chair, Suzanne Jackson, President of Four Leaf Public Relations, handed the gavel to incoming Chair, [...]

Charlottesville, VA — March 1, 2005 — Diffusion Pharmaceuticals LLC, a company that discovers and develops novel small-molecule therapeutics, today announced that it has reached an agreement with the New Approaches to Brain Tumor Therapy CNS Consortium (NABTT) for a comprehensive clinical trials program to test Diffusion’s lead drug candidate, trans sodium crocetinate (TSC), as [...]